1-hexadecanoyl-2-[(9Z)-hexadec-9-enoyl]-sn-glycero-3-phosphoethanolamine zwitterion

Metabolite details

Identifier

CZOSTDZGCCEZTJ-WMHOIYFHSA-N

InChI Key

CZOSTDZGCCEZTJ-WMHOIYFHSA-N

IUPAC name

2-azaniumylethyl (2R)-3-(hexadecanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propyl phosphate

Preferred name

1-hexadecanoyl-2-[(9Z)-hexadec-9-enoyl]-sn-glycero-3-phosphoethanolamine zwitterion

INN name

—

Synonym

1-C_16:0-2-C_16:1(ω-7)-phosphatidylethanolamine zwitterion

ChEBI

CHEBI:73999

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Wild_type_vs_hfq
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• Control_vs_Palmitate
• BSA_Control_vs_AA